Free. Unsubscribe any time.
Candel Therapeutics, Inc. (CADL)
Candel Therapeutics, Inc. filed 11 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 13 transactions and 459,322 shares. 11 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 10 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-11, came 23 days after the one before it (2026-08-19) and reports 4 transactions against 1 in the filing before it.
- The sales it reports total 280,245 shares, 273,245 more than the 7,000 in the filing before it.
- Its 11 plan statements rank 369th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it, 5 have fewer and 1 has the same number.
- Its 11 filings on file run from 2025-03-19 to 2026-09-11, and state no plan adoption date.
Trades in Candel Therapeutics, Inc. 13
- Schoch Charles — 2025-03-17 · S · 5,000 shares
- Tyagarajan Seshu — 2025-03-17 · S · 31,278 shares
- Barone Francesca — 2025-03-18 · S · 32,146 shares
- Nichols William Garrett — 2025-03-18 · S · 45,316 shares
- Tak Paul Peter — 2025-03-18 · S · 25,772 shares
- Tak Paul Peter — 2025-03-19 · S · 400 shares
- Nichols William Garrett — 2025-06-30 · S · 781 shares
- Nichols William Garrett — 2025-07-28 · S · 937 shares
- Barone Francesca — 2026-06-29 · S · 23,447 shares
- Tyagarajan Seshu — 2026-06-29 · S · 7,000 shares
- Tyagarajan Seshu — 2026-08-17 · S · 7,000 shares
- Tak Paul Peter — 2026-09-10 · S · 220,866 shares
Adoption dates in Candel Therapeutics, Inc. 0
Results prints in Candel Therapeutics, Inc. 10
- 2025-01-13
- 2025-03-13
- 2025-05-13
- 2025-08-14
- 2025-10-14
- 2025-11-13
- 2026-02-19
- 2026-03-12
- 2026-05-14
- 2026-08-13
Trades before a print in Candel Therapeutics, Inc. 0
- 17 days before the 2025-08-14 print — 2025-07-28 · S · Nichols William Garrett · 937 shares
- 45 days before the 2025-08-14 print — 2025-06-30 · S · Nichols William Garrett · 781 shares
- 45 days before the 2026-08-13 print — 2026-06-29 · S · Barone Francesca · 23,447 shares
- 45 days before the 2026-08-13 print — 2026-06-29 · S · Tyagarajan Seshu · 7,000 shares
- 55 days before the 2025-05-13 print — 2025-03-19 · S · Tak Paul Peter · 400 shares
- 56 days before the 2025-05-13 print — 2025-03-18 · S · Barone Francesca · 32,146 shares
- 56 days before the 2025-05-13 print — 2025-03-18 · S · Nichols William Garrett · 45,316 shares
- 56 days before the 2025-05-13 print — 2025-03-18 · S · Tak Paul Peter · 25,772 shares
- 57 days before the 2025-05-13 print — 2025-03-17 · S · Schoch Charles · 5,000 shares
- 57 days before the 2025-05-13 print — 2025-03-17 · S · Tyagarajan Seshu · 31,278 shares
Interval to Candel Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 17shortest, days
- 3no later print
Reported results dates on file
- 2025-01-13
- 2025-03-13
- 2025-05-13
- 2025-08-14
- 2025-10-14
- 2025-11-13
- 2026-02-19
- 2026-03-12
- 2026-05-14
- 2026-08-13
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.